Search Results for: PRTK
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > Astellas Pharma (ALPMY) upgraded to Buy from Neutral...
Published:
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Paratek Pharmaceuticals saw its shares take a solid jump early on Friday after the results from its late-stage trial were released.
Published:
Last Updated:
Shares of Paratek Pharmaceuticals saw a huge gain early on Tuesday after the company provided a critical update on its late-stage pneumonia trial.
Published:
Last Updated:
Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to...
Published:
Last Updated:
Thanks to progress made in 2017 though, it looks like 2018 could see both a radically new way of delivering antibiotics and finally the first new class approved in 30 years. Here are three companies...
Published:
Last Updated:
The U.S. Department of Health and Human Services has awarded Paratek Pharmaceuticals a pact to support development of its treatment for pulmonary anthrax.
Published:
Could this small clinical-stage emerging pharmaceuticals outfit have upside of almost 200%? That's what one firm has said on the first trading day of 2019.
Published:
Last Updated:
This Wedbush analyst sees close to 200% in potential upside in Paratek Pharmaceuticals beyond the massive one-day gain on Thursday.
Published:
Tuesday’s top analyst upgrades, downgrades and initiations include ADS, Swift Transportation, Seagate Technology, Synchrony Financial and United Continental.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday include Alphabet, Bank of America, Caterpillar, Nike, NVIDIA, Panera, Snap and Urban Outfitters.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Allergan, Lockheed Martin, Mylan, Nordstrom, Petrobras, NVIDIA, Western Digital.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday include AK Steel, Bloom Energy, Chipotle Mexican Grill, CIT, Cushman & Wakefield, Foot Locker, Sonos and U.S. Steel.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Autodesk, IBM, Lumber Liquidators, NVIDIA, Salesforce.com, Symantec, T-Mobile and Wal-Mart.
Published:
Last Updated:
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
Published:
Last Updated: